Viewing Study NCT02382016



Ignite Creation Date: 2024-05-06 @ 3:49 AM
Last Modification Date: 2024-10-26 @ 11:39 AM
Study NCT ID: NCT02382016
Status: COMPLETED
Last Update Posted: 2019-11-05
First Post: 2015-03-03

Brief Title: PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial
Sponsor: Actelion
Organization: Actelion

Study Overview

Official Title: A Randomized Double-blind Placebo-controlled Prospective Multicenter Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
Status: COMPLETED
Status Verified Date: 2019-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PORTICO
Brief Summary: 24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None